Comparative physiology of mice and rats: Radiometric measurement of vascular parameters in rodent tissues

Molecular Pharmaceutics

Volumn 11, Issue 5, 2014, Pages 1591-1598

  Boswell, C Andrew ^a   Mundo, Eduardo E ^a   Ulufatu, Sheila ^a   Bumbaca, Daniela ^a   Cahaya, Hendry S ^a   Majidy, Nicholas ^a   Van Hoy, Marjie ^a   Schweiger, Michelle G ^a   Fielder, Paul J ^a   Prabhu, Saileta ^a   Khawli, Leslie A ^a,b  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

blood flow; drug delivery; interspecies scaling; interstitial volume; physiology; vascular volume

Indexed keywords

RUBIDIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; AUTORADIOGRAPHY; BLOOD FLOW; BLOOD VOLUME; CELLULAR PARAMETERS; COMPARATIVE STUDY; ERYTHROCYTE; EXTRACELLULAR SPACE; FEMALE; HUMAN; INTRAVASCULAR SPACE; MOUSE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RADIOMETRY; RAT; RODENT; SENSITIVITY ANALYSIS; TISSUE LEVEL; WHOLE BODY IMAGING; ANIMAL; BODY WEIGHT; PHYSIOLOGY; SPRAGUE DAWLEY RAT; THEORETICAL MODEL;

ANIMALS; BLOOD VOLUME; BODY WEIGHT; FEMALE; MICE; MODELS, THEORETICAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899821452     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400748t     Document Type: Article

References (39)

1. Boswell, C. A.; Ferl, G. Z.; Mundo, E. E.; Bumbaca, D.; Schweiger, M. G.; Theil, F. P.; Fielder, P. J.; Khawli, L. A. Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow PLoS One 2011, 6, e17874
2. Boswell, C. A.; Ferl, G. Z.; Mundo, E. E.; Schweiger, M. G.; Marik, J.; Reich, M. P.; Theil, F. P.; Fielder, P. J.; Khawli, L. A. Development and Evaluation of a Novel Method for Preclinical Measurement of Tissue Vascular Volume Mol. Pharmaceutics 2010, 7, 1848-57
3. Brown, R. P.; Delp, M. D.; Lindstedt, S. L.; Rhomberg, L. R.; Beliles, R. P. Physiological parameter values for physiologically based pharmacokinetic models Toxicol. Ind. Health 1997, 13, 407-84
4. Davies, B.; Morris, T. Physiological parameters in laboratory animals and humans Pharm. Res. 1993, 10, 1093-5
5. Baxter, L. T.; Zhu, H.; Mackensen, D. G.; Jain, R. K. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice Cancer Res. 1994, 54, 1517-28
6. Baxter, L. T.; Zhu, H.; Mackensen, D. G.; Butler, W. F.; Jain, R. K. Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model Cancer Res. 1995, 55, 4611-22
7. Blumenthal, R. D.; Osorio, L.; Ochakovskaya, R.; Ying, Z.; Goldenberg, D. M. Regulation of tumour drug delivery by blood flow chronobiology Eur. J. Cancer 2000, 36, 1876-84
8. Boswell, C. A.; Bumbaca, D.; Fielder, P. J.; Khawli, L. A. Compartmental tissue distribution of antibody therapeutics: experimental approaches and interpretations AAPS J. 2012, 14, 612-8
9. Levitt, D. G. The pharmacokinetics of the interstitial space in humans BMC Clin. Pharmacol. 2003, 3, 3
10. Jain, R. K. Transport of molecules in the tumor interstitium: a review Cancer Res. 1987, 47, 3039-51
11. Mordenti, J. Man versus beast: pharmacokinetic scaling in mammals J. Pharm. Sci. 1986, 75, 1028-40
12. Ferl, G. Z.; Wu, A. M.; DiStefano, J. J., III A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal Fc receptor (FcRn) Ann. Biomed Eng. 2005, 33, 1640-52
13. Theil, F. P.; Guentert, T. W.; Haddad, S.; Poulin, P. Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection Toxicol. Lett. 2003, 138, 29-49
14. Garg, A.; Balthasar, J. P. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice J. Pharmacokinet. Pharmacodyn. 2007, 34, 687-709
15. Jain, R. K. Determinants of tumor blood flow: a review Cancer Res. 1988, 48, 2641-58
16. Stott, W. T.; Dryzga, M. D.; Ramsey, J. C. Blood-flow distribution in the mouse J. Appl. Toxicol. 1983, 3, 310-2
17. 99mTc: a new approach to blood pool visualization J. Nucl. Med. 1977, 18, 305-8
18. Sands, H.; Shah, S. A.; Gallagher, B. M. Vascular volume and permeability of human and murine tumors grown in athymic mice Cancer Lett. 1985, 27, 15-21
19. Sands, H.; Jones, P. L.; Shah, S. A.; Palme, D.; Vessella, R. L.; Gallagher, B. M. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts Cancer Res. 1988, 48, 188-93
20. Rehani, M. M.; Sharma, S. K. Site of Tc-99m binding to the red blood cell: concise communication J. Nucl. Med. 1980, 21, 676-8
21. Shockley, T. R.; Lin, K.; Sung, C.; Nagy, J. A.; Tompkins, R. G.; Dedrick, R. L.; Dvorak, H. F.; Yarmush, M. L. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels Cancer Res. 1992, 52, 357-66
22. Sung, C.; Youle, R. J.; Dedrick, R. L. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding Cancer Res. 1990, 50, 7382-92
23. 86Rb Cancer Res. 1974, 34, 1451-6
24. Gullino, P. M.; Grantham, F. H. Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors J. Natl. Cancer Inst. 1962, 28, 211-29
25. Cherry, S. R.; Carnochan, P.; Babich, J. W.; Serafini, F.; Rowell, N. P.; Watson, I. A. Quantitative in vivo measurements of tumor perfusion using rubidium-81 and positron emission tomography J. Nucl. Med. 1990, 31, 1307-15
26. 99mTc-HMPAO as a tumour blood flow agent Eur. J. Nucl. Med. 1987, 13, 90-4
27. Pastuskovas, C. V. Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer model Mol. Cancer Ther. 2012, 11, 752-62
28. Pastuskovas, C. V.; Mallet, W.; Clark, S.; Kenrick, M.; Majidy, M.; Schweiger, M.; Van Hoy, M.; Tsai, S. P.; Bennett, G.; Shen, B. Q.; Ross, S.; Fielder, P.; Khawli, L.; Tibbitts, J. Effect of immune complex formation on the distribution of a novel antibody to the ovarian tumor antigen CA125 Drug Metab. Dispos. 2010, 38, 2309-19
29. Kaliss, N.; Pressman, D. Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins Proc. Soc. Exp. Biol. Med. 1950, 75, 16-20
30. Khor, S. P.; Bozigian, H.; Mayersohn, M. Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat Drug Metab. Dispos. 1991, 19, 486-90
31. Everett, N. B.; Simmons, B.; Lasher, E. P. Distribution of blood (Fe-59) and plasma (I-131) volumes of rats determined by liquid nitrogen freezing Circ. Res. 1956, 4, 419-24
32. Wiig, H.; Kolmannskog, O.; Tenstad, O.; Bert, J. L. Effect of charge on interstitial distribution of albumin in rat dermis in vitro J. Physiol. 2003, 550, 505-14
33. Cesta, M. F. Normal structure, function, and histology of the spleen Toxicol. Pathol. 2006, 34, 455-65
34. Faffe, D. S.; Rocco, P. R.; Negri, E. M.; Zin, W. A. Comparison of rat and mouse pulmonary tissue mechanical properties and histology J. Appl. Physiol. 2002, 92, 230-4
35. Pearse, G. Normal structure, function and histology of the thymus Toxicol. Pathol. 2006, 34, 504-14
36. 111In-labeled anti-TENB2 antibody-drug conjugate J. Nucl. Med. 2012, 53, 1454-61
37. Shah, D. K.; Balthasar, J. P. Physiologically based pharmacokinetic model for topotecan in mice J. Pharmacokinet. Pharmacodyn. 2011, 38, 121-42
38. Urva, S. R.; Yang, V. C.; Balthasar, J. P. Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody J. Pharm. Sci. 2010, 99, 1582-600
39. Wang, W.; Wang, E. Q.; Balthasar, J. P. Monoclonal antibody pharmacokinetics and pharmacodynamics Clin. Pharmacol. Ther. 2008, 84, 548-58